Combined Forehead and Temporal Lifting: An Innovative Approach to Lanluma V Treatment.

Area of Science:

• Aesthetic Medicine
• Dermatology
• Cosmetic Surgery

Background:

• Excess upper facial skin laxity contributes to mid and lower face aging.
• Lanluma V, a poly-l-lactic acid (PLLA) collagen stimulator, is used for facial rejuvenation.
• It stimulates collagen regeneration to support treated areas.

Purpose of the Study:

• To describe an innovative nonsurgical facial rejuvenation technique using Lanluma V injections.
• To evaluate the efficacy and safety of Lanluma V for upper, middle, and lower face rejuvenation.

Main Methods:

• Retrospective review of 12 patients treated with Lanluma V in the scalp's vertex and parietal regions.
• Two treatment sessions were administered, one month apart.
• Patients were assessed by a plastic surgeon using the Global Aesthetic Improvement Scale (GAIS) six months post-treatment.

Main Results:

• Patients achieved an average Global Aesthetic Improvement Scale (GAIS) improvement of 1.16 grades.
• The average follow-up period was six months.
• No incidence of non-scarring alopecia was reported, unlike with other viscous fillers.

Conclusions:

• Lanluma V scalp injections offer an innovative method for forehead and temporal lifting.
• This technique results in an average 1.16 grade improvement in GAIS for facial rejuvenation.
• The treatment avoids the risk of non-scarring alopecia associated with other fillers.